Patient Guide: A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients with Primary Immune Thrombocytopenia

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 83 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04812925
Status: ACTIVE_NOT_RECRUITING
Condition: Primary Immune Thrombocytopenia
Phase: PHASE3

Find a Study Location Near You

This study is available at 83 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Bentonville, Arkansas
  • Washington, District of Columbia
  • Fort Wayne, Indiana
  • • And 80 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily